Suppr超能文献

成人骨髓增生异常综合征患者中年轻患者不良预后标志物的患病率更高——印度一个大型队列的评估

Higher prevalence of poor prognostic markers at a younger age in adult patients with myelodysplastic syndrome - evaluation of a large cohort in India.

作者信息

Srivastava Vivi M, Nair Sukesh Chandran, Joy Melvin, Manipadam Marie-Therese, Kulkarni Uday P, Devasia Anup J, Fouzia N A, Korula Anu, Lakshmi Kavitha M, Jeyaseelan L, Abraham Aby, Srivastava Alok

机构信息

Department of Cytogenetics, Christian Medical College, Vellore, India.

Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, India.

出版信息

Mol Cytogenet. 2024 Sep 27;17(1):21. doi: 10.1186/s13039-024-00687-z.

Abstract

BACKGROUND

The karyotype is a major determinant of prognosis in myelodysplastic syndrome (MDS). Details of the cytogenetic profile of MDS in South Asia are limited because cytogenetic services are not widely available.

METHODS

We performed a retrospective analysis of the cytogenetic and clinicopathologic profile of adult primary MDS seen consecutively at a tertiary-care centre in South India between 2003 and 2017. Patients were re-categorised according to the 2022 World Health Organisation (WHO) and the International Consensus classifications (ICC).

RESULTS

There were 936 patients aged 18-86 years (median age 53, 65% males), with MDS with del 5q, low blasts and increased blasts in 7.5%, 58.4% and 34.1% respectively. Clonal abnormalities were seen in 55% of patients, with solitary abnormalities in 29.8% and complex karyotypes (CK, ≥ 3 abnormalities) in 15%. The most frequent abnormalities were monosomy 7/deletion 7q (16.1%), deletion 5q (14.5%), trisomy 8 (11.5%), and deletion 20q (5.1%). Cytogenetic prognosis groups were distributed as follows: very good, 2%; good, 55.6%; intermediate, 16.2%; poor, 15%; very poor, 11.2%. Clinical (IPSS-R) risk stratification (842 patients) showed: very low-risk, 3.9%; low-risk, 30.9%; intermediate-risk, 24.2%; high-risk, 21%; very high-risk, 20%. Age-adjustment (IPSS-RA) raised the very low-risk group to 12.4%; the other groups decreased by 1-3% each.

CONCLUSION

The most significant finding of this cytogenetic analysis of MDS in India is that abnormal karyotypes with poor prognosis markers including monosomy 7 and CK were more frequent than in most other reports, among patients who were overall younger. Trisomy 8, deletion 20q, the IPSS-R intermediate-risk and both high-risk groups were more common than in the West. Trisomy 8 was less common than in South-East Asia while CK and deletion 20q were comparable. Evaluation of such large cohorts highlights the unique features of MDS in different parts of the world. These findings suggest that there could be differences in predisposing factors, environmental or genetic, and emphasise the need for further exploration to better understand the varied nature of MDS.

摘要

背景

核型是骨髓增生异常综合征(MDS)预后的主要决定因素。由于细胞遗传学检测服务尚未广泛普及,南亚地区MDS的细胞遗传学特征细节有限。

方法

我们对2003年至2017年间在印度南部一家三级医疗中心连续就诊的成年原发性MDS患者的细胞遗传学和临床病理特征进行了回顾性分析。根据2022年世界卫生组织(WHO)和国际共识分类(ICC)对患者进行重新分类。

结果

共有936例年龄在18 - 86岁之间的患者(中位年龄53岁,男性占65%),其中伴有5q缺失、低原始细胞和高原始细胞的MDS患者分别占7.5%、58.4%和34.1%。55%的患者存在克隆性异常,其中孤立性异常占29.8%,复杂核型(CK,≥3种异常)占15%。最常见的异常为7号染色体单体/7q缺失(16.1%)、5q缺失(14.5%)、8号染色体三体(11.5%)和20q缺失(5.1%)。细胞遗传学预后分组分布如下:预后非常好,2%;良好,55.6%;中等,16.2%;差,15%;预后非常差,11.2%。临床(IPSS - R)风险分层(842例患者)显示:极低风险,3.9%;低风险,30.9%;中等风险,24.2%;高风险,21%;极高风险,20%。年龄校正后(IPSS - RA),极低风险组升至12.4%;其他组各下降1 - 3%。

结论

对印度MDS进行的这项细胞遗传学分析最显著的发现是,在总体年龄较轻的患者中,具有不良预后标志物(包括7号染色体单体和CK)的异常核型比大多数其他报告更为常见。8号染色体三体、20q缺失、IPSS - R中等风险组和高风险组均比西方更为常见。8号染色体三体比东南亚少见,而CK和20q缺失情况相当。对如此大规模队列的评估凸显了世界不同地区MDS的独特特征。这些发现表明,在易感因素(环境或遗传)方面可能存在差异,并强调需要进一步探索以更好地理解MDS的多样性本质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cbe/11438259/b92c681cf3d0/13039_2024_687_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验